Showing 5,845 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

ViiV Healthcare announces positive CHMP opinion for Rukobia (fostemsavir), a first-in-class attachment inhibitor for the treatment of adults with multidrug-resistant HIV with few treatment options available

Editor's pick
ViiV Healthcare press release
11 December 2020
Weight gain & lipodystrophy

More weight gain in people starting HIV treatment with newer integrase inhibitors or darunavir

News
11 December 2020
Treatment outcomes & life expectancy

WHO reveals leading causes of death and disability worldwide: 2000-2019

Editor's pick
World Health Organization
10 December 2020
Treatment outcomes & life expectancy

Hospitalization Rates Have Declined Among People With HIV

Editor's pick
POZ
10 December 2020
PrEP programmes & uptake

Voucher scheme to encourage young South African women to take PrEP has modest impact

Editor's pick
Avert
10 December 2020
HIV treatment

Top 10 HIV Clinical Developments of 2020

Editor's pick
TheBodyPro
1 December 2020
Retention & linkage to care

South Africa: ‘Welcome Back Service’ aims to help people get back on HIV treatment

Editor's pick
Spotlight
1 December 2020
Drug interactions & pharmacokinetics

Can HIV Meds Interact With COVID-19 Treatment? Here's What We Know

Editor's pick
TheBody
25 November 2020
Treatment outcomes & life expectancy

US: HIV-Related Deaths Decline, but Disparities Still Exist Among Multiple Populations

Editor's pick
American Journal of Managed Care
24 November 2020
Ethnic & cultural minorities

UK: Black people less likely to be engaged in HIV care, with more cases of viral rebound

News
23 November 2020
Tuberculosis & HIV

TB policies aren't working. Here's why.

Editor's pick
Devex
20 November 2020
New & experimental HIV treatments

Data sets up 2021 filings for Gilead's twice-a-year HIV drug lenacapavir

Editor's pick
Pharmaphorum
20 November 2020
Injectable & long-acting HIV treatment

A Long-Lasting, More Effective HIV Drug Is A Psychological Relief For Patients

Editor's pick
NPR
20 November 2020
New & experimental HIV treatments

Gilead Announces Investigational Long-Acting HIV-1 Capsid Inhibitor, Lenacapavir, Achieves Primary Endpoint in Phase 2/3 Study in Heavily Treatment-Experienced People Living With HIV

Editor's pick
Gilead press release
20 November 2020
Treatment outcomes & life expectancy

H.I.V. Death Rates Fell by Half 2010-2018, C.D.C. Says

Editor's pick
New York Times
20 November 2020
Treatment outcomes & life expectancy

Millions of people are on treatment for HIV: why are so many still dying?

Editor's pick
The Conversation
18 November 2020
HIV testing programmes & uptake

Almost half of HIV diagnoses in Europe are late, with serious impact on health outcomes

News
18 November 2020
HIV treatment for children & young people

New neonatal liquid formulations of dolutegravir have comparable bioavailability to dispersible paediatric tablet

Editor's pick
i-Base
16 November 2020
Improving HIV care

Escalate HIV Adherence Strategies Amid COVID-19

Editor's pick
Medscape (requires free registration)
16 November 2020
Weight gain & lipodystrophy

Women Show Higher INSTI-Associated Weight Gain and Incident Diabetes Mellitus Than Men

Editor's pick
Infectious Disease Advisor
12 November 2020
Hepatitis & HIV

European HIV doctors conduct their first-ever region-wide audit of services

News
11 November 2020
Weight gain & lipodystrophy

Diabetes drug may aid weight loss in people with HIV

News
6 November 2020
Injectable & long-acting HIV treatment

Long-acting injectables appear feasible for long-term HIV treatment

News
4 November 2020
The search for a cure

Could a multiple sclerosis medication be used against the HIV reservoir?

News
2 November 2020